Definitive Contract HR001126CE009

The Defense Advanced Research Projects Agency (DARPA) awarded a $692,875 firm fixed-price definitive contract to The Council on Strategic Risks on October 21, 2025, for work under the Biological Technologies Office's SWITCH Program. The contract will be performed in Washington, DC and is scheduled for completion by February 20, 2028. No set-aside designation was utilized for this award.

The SWITCH Program represents DARPA's investment in biological technology research and development with strategic implications for national defense. The Council on Strategic Risks, a nonpartisan organization focused on emerging risks at the intersection of technology, security, and society, will support officewide biological technologies initiatives under this contract. The firm fixed-price structure indicates that costs are predetermined, providing budget certainty for this effort spanning approximately 2.3 years.